ImmunAge Medical

ImmunAge Medical is a biotechnology company dedicated to reversing immunosenescence, the age-related decline of the immune system. Founded by Dr. Michael D. West, a pioneer in regenerative medicine and telomere biology, the company utilizes induced pluripotent stem cell (iPSC) technology to rejuvenate critical immune components such as the thymus and hematopoietic stem cells. Their mission is to restore youthful immune surveillance and function to better protect the elderly against infectious diseases, cancer, and chronic inflammatory conditions. By leveraging advanced cellular reprogramming, ImmunAge aims to extend the human healthspan by addressing the root causes of immune system failure. The company operates at the forefront of longevity science, translating decades of research into potential therapeutic interventions for age-related diseases.